Maria Riedmeier, Sonir R R Antonini, Silvia Brandalise, Tatiana El Jaick B Costa, Camila M Daiggi, Bonald C de Figueiredo, Ronald R de Krijger, Karla Emília De Sá Rodrigues, Cheri Deal, Jaydira Del Rivero, Gernot Engstler, Martin Fassnacht, Gabriela C Fernandes Luiz Canali, Carlos A Fernandes Molina, Elmas Nazli Gonc, Melis Gültekin, Harm R Haak, Tulay Guran, Emile J Hendriks A, Jan Idkowiak, Michaela Kuhlen, David Malkin, Jagdish Prasad Meena, Christina Pamporaki, Emilia Pinto, Soraya Puglisi, Raul C Ribeiro, Lester D R Thompson, Bilgehan Yalcin, Max Van Noesel, Verena Wiegering
OBJECTIVE: Mitotane is an important cornerstone in the treatment of pediatric adrenal cortical tumors (pACC), but experience with the drug in the pediatric age group is still limited and current practice is not guided by robust evidence. Therefore, we have compiled international consensus statements from pACC experts on mitotane indications, therapy, and management of adverse effects. METHODS: A Delphi method with three rounds of questionnaires within the pACC expert consortium of the international network groups ENSAT-PACT and ICPACT was used to create 21 final consensus statements...
March 29, 2024: European Journal of Endocrinology